# clm_8A05921A46AB

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: quarterly_revenue  
value: 11,895,000,000 United States dollar  
valid_from: 2022-03-31  
valid_to: 2022-06-30  
published: 2022-05-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_3FFAC71D1875  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories quarterly revenue: 11,895,000,000 United States dollar", as of 2022-03-31 (until 2022-06-30). Claim clm_8A05921A46AB, https://asof.is/claim/clm_8A05921A46AB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000110465922055285/0001104659-22-055285-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2022, filed 2022-05-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000110465922055285/0001104659-22-055285-index.htm (primary, SEC EDGAR 10-Q Q1 FY2022, published 2022-05-03)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | quarterly_revenue | 10,928,000,000 United States dollar | valid 2021-09-30 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_8A05921A46AB](/claim/clm_8A05921A46AB.md) | [clm_D28ACE81B29C](/claim/clm_D28ACE81B29C.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.